IR Sant Pau to Lead Synapsing, an Innovative Horizon-Europe Programme Project to Advance the Diagnosis and Treatment of Psychiatric Disorders and Neurodegenerative Diseases
The Sant Pau Research Institute (IR Sant Pau) has been selected to coordinate the ambitious European project Synapsing, an unprecedented initiative funded with seven million euros by the European Union through the Horizon-Europe programme. This project, involving...
Characterization of white matter hyperintensities in Down syndrome
White matter hyperintensities (WMH) are one of the imaging biomarkers of small vessel disease of presumed vascular origin. These lesions can be shown as areas of increases signal on fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging. WMH are...
New plasma biomarker to detect Alzheimer’s disease in Down syndrome individuals
Plasma biomarkers Scientists worldwide are immersed in the race for accurate, non-invasive and accessible biomarkers to detect and diagnose Alzheimer’s Disease. To date, major scientific advances allowed the identification of several biomarkers in cerebrospinal fluid...
Dr. Oriol Dols-Icardo, awarded by Fundación hna
Research award by Fundación hna Fundación hna has awarded Dr. Oriol Dols-Icardo the prize of the first edition of the “Premio de Investigación Científica de Salud“. This is a competitive call for funding a research project on Amyotrophic Lateral Sclerosis...
Blood biomarkers are useful to detect Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease Recent developments in blood markers have made possible to track the different pathophysiological processes that occur in Alzheimer’s disease through plasma analysis. Our study “Use of plasma biomarkers for AT...
What is the value of brain atrophy in frontotemporal dementia?
Atrophy and frontotemporal dementia The behavioral variant of frontotemporal dementia is a frequent cause of neurodegenerative dementia and the first cause of Frontotemporal Lobular Degeneration. Patients with the behavioral variant of frontotemporal dementia present...
Marta Querol defends her doctoral thesis
Marta Querol Vilaseca has presented her doctoral thesis entitled “New methods of digital neuropathology applied to neurodegenerative diseases“. The thesis has been directed and tutored by Dr. Alberto Lleó, and discusses new methodologies that are useful to...
Structural changes in the brain of patients with Alzheimer’s begin 20 years before the symptoms onset
Structural brain changes in Alzheimer’s disease Brain alterations in Alzheimer’s disease patients begin years before symptoms appear and a clinical diagnosis can be made. The neuroimaging team in our group has developed a technique that measures the...